Involvement of P2Y11 receptor in silica nanoparticles 30-induced IL-6 production by human keratinocytes

Toxicology

Volumn 322, Issue , 2014, Pages 61-68

  Nagakura, Chihiro ^a   Negishi, Yusuke ^a   Tsukimoto, Mitsutoshi ^a   Itou, Satomi ^a   Kondo, Takeshi ^a   Takeda, Ken ^a   Kojima, Shuji ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

ATP; IL 6 production; P2Y11 receptor; Skin inflammation; SNP30

Indexed keywords

ADENOSINE TRIPHOSPHATE; GAMMA INTERFERON; INTERLEUKIN 6; NANOPARTICLE; NUCLEOTIDASE; PURINERGIC P2Y11 RECEPTOR; SILICON DIOXIDE; SURAMIN; TUMOR NECROSIS FACTOR ALPHA; URIDINE TRIPHOSPHATE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ATP; IL-6 PRODUCTION; P2Y11 RECEPTOR; SKIN INFLAMMATION; SNP30;

ADENOSINE TRIPHOSPHATE; CELL SURVIVAL; DERMATITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDICATORS AND REAGENTS; INTERFERON-GAMMA; INTERLEUKIN-6; KERATINOCYTES; NANOPARTICLES; PARTICLE SIZE; PURINERGIC P2Y RECEPTOR AGONISTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2; SILICON DIOXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901609338     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2014.03.010     Document Type: Article

References (56)

1. Abbracchio M.P., Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors?. Pharmacol. Ther. 1994, 64:445-475.
2. Aillon K., Xie Y., El-Gendy N., Berkland C.J., Forrest M.L. Effects of nano-material physicochemical properties on in vivo toxicity. Adv. Drug 2009, 61(6):457-466.
3. Ansel J., Perry P., Brown J., Damm D., Phan T., Hart C., Luger T., Hefeneider S. Cytokine modulation of keratinocyte cytokines. J. Invest. Dermatol. 1990, 94:101S-107S.
4. Azorin N., Raoux M., Rodat-Despoix L., Merrot T., Delmas P., Crest M. ATP signalling is crucial for the response of human keratinocytes to mechanical stimulation by hypo-osmotic shock. Exp. Dermatol. 2011, 20:401-407.
5. Bingle C.D., Sabroe I., Surprenant A., Whyte M.K. Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J. Immunol. 2007, 179:8544-8553.
6. Boudreault F., Grygorczyk R. Cell swelling-induced ATP release is tightly dependent on intracellular calcium elevations. J. Physiol. 2004, 561:499-513.
7. Bowman P.D., Schuschereba S.T., Lawlor D.F., Gilligan G.R., Mata J.R., DeBaere D.R. Survival of human epidermal keratinocytes after short duration high temperature: synthesis of HSP70 and IL-8. Am. J. Physiol. 1997, 272:C1988-C1994.
8. Burnstock G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 1997, 36:1127-1139.
9. Burrell H.E., Bowler B., Gallagher J.A., Sharpe G.R. Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. J. Invest. Dermatol. 2003, 120:440-447.
10. Corriden R., Insel P.A. Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci. Signal. 2010, 3. re 1.
11. Crosera M., Bovenzi M., Maina G., Adami G., Zanette C., Florio C., Larese F.F. Nanoparticle dermal absorption and toxicity: a review of the literature. Int. Arch. Occup. Environ. Health 2009, 82:1043-1055.
12. Dixon G.J., Bowler W.B., Littlewood-Evans A., Bilbe G., Sharpe G.R., Gallagher J.A. Regulation of epidermal homeostasis through P2Y2 receptors. Br. J. Pharmacol. 1999, 127:1680-1686.
13. Donaldson K., Tran L., Jimenez L.A., Duffin R., Newby D.E., Mills N., MacNee W., Vicki Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part. Fibre Toxicol. 2005, 2(10). 10.1186/1743-8977-2-10.
14. Dubyak G.R., el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 1993, 265:C577-C606.
15. Elder J.T., Fischer G.J., Lindquist P.B., Bennett G.L., Pittelkow M.R., Coffey, Ellingsworth L., Derynck R., Voorh J.J. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 1989, 243:811-814.
16. Farrar M.A., Schreiber R.D. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 1993, 11:571-611.
17. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Melchiorri L., Baricordi O.R., Di Virgilio F. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 1997, 159:1451-1458.
18. Fitz J.G. Regulation of cellular ATP release. Trans. Am. Clin. Climatol. Assoc. 2007, 118:199-208.
19. Gallucci R.M., Sloan D.K., Heck J.M., Murray A.R., O'Dell S.J. Interleukin 6 indirectly induces keratinocyte migration. J. Invest. Dermatol. 2004, 122:764-772.
20. Greig A.V.H., Linge C., Terenghi G., McGrouther D.A., Burnstock G. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J. Invest. Dermatol. 2003, 120:1007-1015.
21. Gröne A. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 2002, 88:1-12.
22. Hisadome K., Koyama T., Kimura C., Droogmans G., Ito Y., Oike M. Volume-regulated anion channels serve as an auto/paracrine nucleotide release pathway in aortic endothelial cells. J. Gen. Physiol. 2002, 119:511-520.
23. Inoue K., Hosoi J., Denda M. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J. Invest. Dermatol. 2007, 127:362-371.
24. 11 receptor in IFN-γ-induced IL-6 production in human keratinocytes. Eur. J. Pharmacol. 2013, 703:67-73.
25. Kawakami M., Kaneko N., Anada H., Terai C., Okada Y. Measurement of interleukin-6, interleukin-10, and tumor necrosis factor-alpha levels in tissues and plasma after thermal injury in mice. Surgery 1997, 121:440-448.
26. Kirnbauer R., Kock A., Schwarz T., Urbanski A., Krutmann J., Borth W., Damm D., Shipley G., Ansel J.C., Luger T.A. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J. Immunol. 1989, 142:1922-1928.
27. Kirnbauer R., Kock A., Neuner P., Förster E., Krutmann J., Urbanski A., Schauer E., Ansel J.C., Schwarz T., Luger A. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroiods. J. Invest. Dermatol. 1991, 96:484-489.
28. Kock A., Schwarz T., Kirnbauer R., Urbanski A., Perry P., Ansel J.C., Luger T.A. Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 1990, 172:1609-1614.
29. 2+-activated ion channels in human keratinocytes. FASEB J. 2001, 15:145-154.
30. 2+ waves in keratinocytes are transmitted to sensory neurons: the involvement of extracellular ATP and P2Y2 receptor activation. Biochem. J. 2004, 380:329-338.
31. Kondo S., Kono T., Sauder D.N., McKenzie R.C. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J. Invest. Dermatol. 1993, 101:690-694.
32. Lazarowski E.R., Boucher R.C., Harden T.K. Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J. Biol. Chem. 2000, 275:31061-31068.
33. Luo X., Morrin A., Killard A.J., Smyth M.R. Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis 2006, 4:319-326.
34. Manke A., Wang L., Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. BioMed Res. Int. 2007, 2013:942916. (15 p.). 10.1155/2013/942916.
35. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150:552-558.
36. Mizumoto N., Mummert M.E., Shalhevet D., Takashima A. Keratinocytes ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J. Invest. Dermatol. 2003, 121:1066-1072.
37. Napierska D., Thomassen L.C.J., Lison D., Martens J.A., Hoet P. The nanosilica hazard: another variable entity. Part. Fibre Toxicol. 2010, 7:39.
38. Neuner P., Urbanski A., Trautinger F., Moller A., Kirnbauer R., Kapp A., Schopf E., Schwarz T., Luger T.A. Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J. Invest. Dermatol. 1991, 97:27-33.
39. Ohshima Y., Tsukimoto M., Takenouchi T., Harada H., Suzuki A., Sato M., Kitani H., Kojima S. Gamma-irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells. Biochim. Biophys. Acta 2010, 1800:40-46.
40. Pankratov Y., Lalo U., Verkhratsky A., North R.A. Vesicular release of ATP at central synapses. Pflugers Arch. 2006, 452:589-597.
41. Partridge M., Chantry D., Turner M., Feldmann M. Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines. J. Invest. Dermatol. 1991, 96:771-776.
42. Pastore S., Mascia F., Gulinelli S., Forchap S., Dattilo C., Adinolfi E., Girolomoni G., Di Virgilio F., Ferrari D. Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes. J. Invest. Dermatol. 2006, 127:660-667.
43. Pellegatti P., Falzoni S., Pinton P., Rizzuto R., Di Virgilio F. A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 2005, 16:3659-3665.
44. Sabirov R.Z., Dutta A.K., Okada Y. Volume-dependent ATP-conductive large-conductance anion channel as a pathway for swelling-induced ATP release. J. Gen. Physiol. 2001, 118:251-266.
45. Schwarz T., Luger T.A. Effect of UV irradiation on epidermal cell cytokine production. J. Photochem. Photobiol. B 1989, 4:1-13.
46. Sprague R.S., Ellsworth M.L., Stephenson A.H., Kleinhenz M.E., Lonigro A.J. Deformation-induced ATP release from red blood cells requires CFTR activity. Am. J. Physiol. 1998, 275:1726-1732.
47. Stout C.E., Costantin J.L., Naus C.C., Charles A.C. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J. Biol. Chem. 2002, 277:10482-10488.
48. Tsukimoto M., Homma T., Ohshima Y., Kojima S. Involvement of purinergic signaling in cellular response to gamma radiation. Radiat. Res. 2010, 173:298-309.
49. Uratsuji H., Tada Y., Kawashima T., Kamata M., Hau C.S., Asano Y., Sugaya M., Kadono T., Asahina A., Sato S., Tamaki K. P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. J. Immunol. 2012, 188:436-444.
50. Urbanski A., Schwarz T., Neuner P., Krutmann J., Kirnbauer R., Kock A., Luger T.A. Ultraviolet light induces increased circulating interleukin-6 in humans. J. Invest. Dermatol. 1990, 94:808-811.
51. Uskoković V. Entering the era of nanoscience: time to be so small. J. Biomed. Nanotechnol. 2013, 9:1441-1470.
52. Wilkin F., Duhant X., Bruyns C., Suarez-Huerta N., Boeynaems J.M., Robaye B. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 2001, 166:7172-7177.
53. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
54. Yang W., Peters J.I., William R.O. Inhaled nanoparticles-a current review. Int. J. Pharm. 2008, 456:239-247.
55. Yoshida H., Kobayashi D., Ohkubo S., Nakahata N. ATP stimulates interleukin-6 production via P2Y receptors in human HaCaT keratinocytes. Eur. J. Pharmacol. 2006, 540:1-9.
56. Zhang G., Zeng X., Li P. Nanomaterials in cancer-therapy drug delivery system. J. Biomed. Nanotechnol. 2013, 9:741-750.